Intellia Therapeutics officer proposes $736K sale

The notice also reports that Eliana Clark sold 10,964 common shares on August 10, 2026, for an aggregate value of $129,382.94.

Rhea-AI Filing Summary

Intellia Therapeutics, Inc. officer Eliana Clark gave notice of a proposed sale of 57,750 common shares, with an aggregate market value of $736,312.50. The notice lists Morgan Stanley Smith Barney LLC as broker, Nasdaq as the exchange, and October 5, 2026, as the approximate sale date. It lists the shares as acquired from the issuer through a stock option exercise for cash on October 5, 2026.

Key Figures

Common shares proposed for sale: 57,750 shares Aggregate market value: $736,312.50 Common shares outstanding: 140,126,693 shares +2 more

5 metrics

Common shares proposed for sale 57,750 shares Approximate sale date October 5, 2026

Aggregate market value $736,312.50 Proposed sale

Common shares outstanding 140,126,693 shares Number reported in the notice

Common shares sold 10,964 shares Sale on August 10, 2026, during the prior three months

Aggregate value $129,382.94 Sale on August 10, 2026

Key Terms

Rule 144, Stock Option Exercise, aggregate market value

3 terms

Rule 144 regulatory

"paragraph (a) of Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Stock Option Exercise financial

"Stock Option Exercise"

A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.

aggregate market value financial

"aggregate market value of securities to be sold"

Aggregate market value is the combined price you would pay to buy all outstanding shares of a company or all companies in a group at current market prices — essentially the sum of each stock’s market capitalization. It matters to investors because it shows the overall size and weight of an investment or sector (like the total cost to buy every piece of a puzzle), helps compare scale across companies or markets, and influences index composition and risk exposure.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many NTLA shares did Eliana Clark plan to sell?

Eliana Clark, an Intellia Therapeutics officer, reported a proposed sale of 57,750 common shares with an aggregate market value of $736,312.50. The approximate sale date was October 5, 2026, through Morgan Stanley Smith Barney LLC on Nasdaq.

How many NTLA shares did Eliana Clark sell in the prior three months?

The notice lists 10,964 common shares sold on August 10, 2026, for an aggregate value of $129,382.94.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 10/05/2026 - 04:46 PM Accepted by SEC EDGAR 10/05/2026 - 04:45 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001914448
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	INTELLIA THERAPEUTICS, INC.
SEC File Number	001-37766
Address of Issuer	400 Technology Square, Suite 100 Cambridge MASSACHUSETTS 02139
Phone	857-285-6200
Name of Person for Whose Account the Securities are To Be Sold	ELIANA CLARK
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	57750	736312.50	140126693	10/05/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	10/05/2026	Stock Option Exercise	Issuer			57750	10/05/2026	Cash

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
ELIANA CLARK 400 Technology Square, Suite 100 Cambridge MA 02139	Common	08/10/2026	10964	129382.94

144: Remarks and Signature

Remarks
Date of Notice	10/05/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Eliana D Clark
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)